SHANGHAI SANYOU MEDICAL CO., LTD Shanghai Sanyou Medical Co., Ltd Stock
Equities
688085
CNE1000040J7
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.8 CNY | +3.01% |
|
+7.43% | -3.59% |
| Sales 2024 * | 706M 97.4M | Sales 2025 * | 863M 119M | Capitalization | 4.67B 645M |
|---|---|---|---|---|---|
| Net income 2024 * | 157M 21.67M | Net income 2025 * | 218M 30.09M | EV / Sales 2024 * | 6.62 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.41 x |
| P/E ratio 2024 * |
29.8
x | P/E ratio 2025 * |
21.4
x | Employees | 434 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 46.17% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.01% | ||
| 1 week | +7.43% | ||
| Current month | +20.75% | ||
| 1 month | +24.42% | ||
| 3 months | +15.27% | ||
| 6 months | -5.86% | ||
| Current year | -3.59% |
1 week
17.40
18.88
1 month
14.9118.88
Current year
11.9719.65
1 year
11.9732.04
3 years
11.9737.99
5 years
11.9774.30
10 years
11.9774.30
| Managers | Title | Age | Since |
|---|---|---|---|
David Fan
FOU | Founder | 55 | 05-04-18 |
Ming Yan Liu
FOU | Founder | 67 | 05-04-18 |
Nong Xu
FOU | Founder | 60 | 05-04-18 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xu Bo Hu
BRD | Director/Board Member | 49 | 14-04-30 |
Nong Xu
FOU | Founder | 60 | 05-04-18 |
Ming Yan Liu
FOU | Founder | 67 | 05-04-18 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 18.8 | +3.01% | 1,647,773 |
| 24-04-24 | 18.25 | -0.27% | 1,390,494 |
| 24-04-23 | 18.3 | +0.66% | 1,262,389 |
| 24-04-22 | 18.18 | +2.83% | 1,943,006 |
| 24-04-19 | 17.68 | +1.03% | 951,565 |
End-of-day quote Shanghai S.E., April 24, 2024
More quotes
Shanghai Sanyou Medical Co Ltd is a China-based company mainly engaged in medical equipment business. The Company's main business is the research, development, manufacturing and sales of medical orthopedic implant consumables. Its main products include spinal implant consumable products and trauma implant consumable products. In addition, the Company also develops and produces supporting surgical tools. The Company distributes its products within domestic market and to overseas markets.
Calendar
2024-04-25
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
18.8
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -3.59% | 645M | |
| +72.64% | 12.34B | |
| -18.30% | 7.96B | |
| +15.38% | 7.16B | |
| +4.95% | 5.72B | |
| +6.51% | 5.03B | |
| +21.99% | 4.35B | |
| -21.67% | 3.99B | |
| -41.36% | 2.21B | |
| +0.37% | 2.01B |
- Stock Market
- Equities
- 688085 Stock
